Chen ZS et al. |
Early steroid withdrawal after liver transplantation for hepatocellular carcinoma. |
2007 |
World J. Gastroenterol. |
pmid:17876900
|
Provenzani A et al. |
Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients. |
2013 |
World J. Gastroenterol. |
pmid:24409044
|
Liu F et al. |
Tacrolimus dosage requirements in living donor liver transplant recipients with small-for-size grafts. |
2009 |
World J. Gastroenterol. |
pmid:19701975
|
Del Bello A et al. |
High tacrolimus intra-patient variability is associated with graft rejection, and donor-specific antibodies occurrence after liver transplantation. |
2018 |
World J. Gastroenterol. |
pmid:29713132
|
Meier J and Sturm A |
Current treatment of ulcerative colitis. |
2011 |
World J. Gastroenterol. |
pmid:21912469
|
Okan G et al. |
Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus. |
2008 |
World J. Gastroenterol. |
pmid:18698687
|
Akamatsu N et al. |
Late-onset acute rejection after living donor liver transplantation. |
2006 |
World J. Gastroenterol. |
pmid:17075982
|
Kiyama T et al. |
Tacrolimus enhances colon anastomotic healing in rats. |
2002 Sep-Oct |
Wound Repair Regen |
pmid:12406167
|
Gupta AS et al. |
Pyoderma Gangrenosum of the Scalp: A Rare Clinical Variant. |
2018 |
Wounds |
pmid:29481333
|
Zhou YN et al. |
Effect of amlodipine on the pharmacokinetics of tacrolimus in rats. |
2013 |
Xenobiotica |
pmid:23312000
|
Picard N |
The pharmacokinetic interaction between mycophenolic acid and cyclosporine revisited: a commentary on "Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus". |
2013 |
Xenobiotica |
pmid:23339626
|
Fujiyama N et al. |
Influence of carboxylesterase 2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients. |
2009 |
Xenobiotica |
pmid:19274604
|
Tata PN et al. |
Species-dependent hepatic metabolism of immunosuppressive agent tacrolimus (FK-506). |
2009 |
Xenobiotica |
pmid:19604035
|
Zhang S et al. |
Effect of voriconazole and other azole antifungal agents on CYP3A activity and metabolism of tacrolimus in human liver microsomes. |
2012 |
Xenobiotica |
pmid:22106961
|
Ogawa K et al. |
A new approach to predicting human hepatic clearance of CYP3A4 substrates using monkey pharmacokinetic data. |
2013 |
Xenobiotica |
pmid:23153054
|
Lu XF et al. |
Use of a semi-physiological pharmacokinetic model to investigate the influence of itraconazole on tacrolimus absorption, distribution and metabolism in mice. |
2017 |
Xenobiotica |
pmid:27533047
|
Zhu L et al. |
Effects of CYP3A5 genotypes, ABCB1 C3435T and G2677T/A polymorphism on pharmacokinetics of Tacrolimus in Chinese adult liver transplant patients. |
2015 |
Xenobiotica |
pmid:25869250
|
Lampen A et al. |
Catalytic activities, protein- and mRNA-expression of cytochrome P450 isoenzymes in intestinal cell lines. |
1998 |
Xenobiotica |
pmid:9622846
|
Jeong H and Chiou WL |
Role of P-glycoprotein in the hepatic metabolism of tacrolimus. |
2006 |
Xenobiotica |
pmid:16507509
|
Patel CG et al. |
Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus. |
2013 |
Xenobiotica |
pmid:22934787
|
Chitnis SD et al. |
Concentration of tacrolimus and major metabolites in kidney transplant recipients as a function of diabetes mellitus and cytochrome P450 3A gene polymorphism. |
2013 |
Xenobiotica |
pmid:23278282
|
Miura M et al. |
Comparison of enantioselective disposition of rabeprazole versus lansoprazole in renal-transplant recipients who are CYP2C19 extensive metabolizers. |
2005 |
Xenobiotica |
pmid:16012079
|
Niioka T et al. |
Effects of CYP3A5 polymorphism and the tacrolimus 12 h concentration on tacrolimus-induced acute renal dysfunction in patients with lupus nephritis. |
2015 |
Xenobiotica |
pmid:26189776
|
Imamura R et al. |
ABO-incompatible kidney transplantation with anti-CD20 monoclonal antibodies, intravenous immunoglobulin and plasmapheresis without splenectomy: a case report. |
2006 |
Xenotransplantation |
pmid:16623807
|
Song Z et al. |
Tacrolimus inhibits discordant islet xenograft rejection: a study in the pig-to-rat model. |
2003 |
Xenotransplantation |
pmid:14617270
|
Balamurugan AN et al. |
Effect of various immunosuppressive monotherapies on survival and histopathology of monkey islet xenografts in rats. |
2007 |
Xenotransplantation |
pmid:17669173
|
Miki T et al. |
Hamster-to-rat bone marrow xenotransplantation and humoral graft vs. host disease. |
2001 |
Xenotransplantation |
pmid:11472629
|
Tachibana A et al. |
Repopulation of the immunosuppressed retrorsine-treated infant rat liver with human hepatocytes. |
2013 Jul-Aug |
Xenotransplantation |
pmid:23683097
|
Li J et al. |
[Regulatory effect of FK506 on the expression of CD152 and PD-1 in the liver allo-recipients]. |
2008 |
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi |
pmid:18177621
|
He QH et al. |
[The role of superantigen SEB-induced immunotolerance in the immune privileged site]. |
2003 |
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi |
pmid:15132898
|
Bai YJ et al. |
[Regulatory function of tacrolimus and CsA on CD4/CD8 T lymphocyte subgroups and costimulators on them in allo-liver recipients]. |
2008 |
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi |
pmid:18845086
|
Pan ZX et al. |
[IL-18 expression in whole blood cell cultures from active lupus nephritis and the inhibitory effects of FK506, cyclosporin A and dexamethasone]. |
2004 |
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi |
pmid:15555450
|
Kagaya H et al. |
Quantification and 24-hour monitoring of mycophenolic acid by high-performance liquid chromatography in Japanese renal transplant recipients. |
2006 |
Yakugaku Zasshi |
pmid:17139160
|
Tayama Y et al. |
[Influence of tacrolimus and ciprofloxacin on glucose metabolism]. |
2007 |
Yakugaku Zasshi |
pmid:17978565
|
Naito T |
[Optimal immunosuppressive therapy based on pharmacokinetics and pharmacodynamics of antimetabolites in clinical practice]. |
2010 |
Yakugaku Zasshi |
pmid:21139397
|
Yamaguchi K et al. |
[Case of encephalopathy seemingly caused by tacrolimus at blood concentration near the upper limit of therapeutic range]. |
2012 |
Yakugaku Zasshi |
pmid:22790031
|
Nagao K et al. |
[Drug development from natural fermentation products: establishing a manufacturing process which maximizes the potential of microorganisms]. |
2010 |
Yakugaku Zasshi |
pmid:21048405
|
Fukudo M |
[Individualized dosage regimen of immunosuppressive drugs based on pharmacokinetic and pharmacodynamic analysis]. |
2007 |
Yakugaku Zasshi |
pmid:17603267
|
Sood S and Muthuraman A |
Activity of tacrolimus: an immunosuppressant, in pyloric ligation-induced peptic ulcer in the rat. |
2009 |
Yakugaku Zasshi |
pmid:19952532
|
Tanaka H et al. |
[Discovery and development of a novel immunosuppressant, tacrolimus hydrate]. |
1997 |
Yakugaku Zasshi |
pmid:9306728
|
Muraki Y |
[Factors affecting the pharmacokinetics after living donor liver transplant]. |
2012 |
Yakugaku Zasshi |
pmid:23023417
|
Iwamoto T et al. |
[Successful treatment by tacrolimus in two patients with Osserman's grade III intractable myasthenia gravis and elderly IIb]. |
2004 |
Yakugaku Zasshi |
pmid:15067188
|
Uchida K et al. |
Pharmacokinetics of orally administered tacrolimus in lupus nephritis patients. |
2010 |
Yakugaku Zasshi |
pmid:20046074
|
Niwa T et al. |
Effect of cyclosporine and tacrolimus on cytochrome p450 activities in human liver microsomes. |
2007 |
Yakugaku Zasshi |
pmid:17202802
|
Shimizu K |
Development of New Liposome Targeting Strategies for Application of Disease Therapies. |
2017 |
Yakugaku Zasshi |
pmid:28049894
|
Tanaka Y et al. |
[Effect of tacrolimus on the pharmacokinetics and glucuronidation of SN-38, an active metabolite of irinotecan]. |
2013 |
Yakugaku Zasshi |
pmid:23328499
|
Wang M et al. |
Studies on the effects of the immunosuppressant FK-506 on the high-risk corneal graft rejection. |
2002 |
Yan Ke Xue Bao |
pmid:15510746
|
Li S et al. |
Experiment study of retinal ultrastructure after intravitreal FK506. |
2004 |
Yan Ke Xue Bao |
pmid:15124532
|
Xie H et al. |
Effect of topical FK506 used alone or combined with keratoplasty on patients with recurrent Mooren's corneal ulcer. |
2006 |
Yan Ke Xue Bao |
pmid:17378150
|
Ma H et al. |
[The effect of FK506 on the proliferation of HRCECs]. |
2006 |
Yan Ke Xue Bao |
pmid:17378157
|